The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
van Leeuwen CM, Oei AL, Crezee J, Bel A, Franken NAP, Stalpers LJA, Kok HP.
Radiat Oncol. 2018 May 16;13(1):96. doi: 10.1186/s13014-018-1040-z.
PMID:29769103
Active Immune Phenotype in Head and Neck Cancer: Reevaluating the Iso-Effect Fractionation Based on the Linear Quadratic (LQ) Model-A Narrative Review.
Mireștean CC, Iancu RI, Iancu DPT.
Curr Oncol. 2023 May 8;30(5):4805-4816. doi: 10.3390/curroncol30050362.
PMID:37232820
A linear-quadratic model of cell survival considering both sublethal and potentially lethal radiation damage.
Lymphocyte radiosensitivity: An extension to the linear-quadratic model?
Pham TN, Coupey J, Thariat J, Valable S.
Radiother Oncol. 2024 Sep;198:110406. doi: 10.1016/j.radonc.2024.110406. Epub 2024 Jun 24.
PMID:38925262
Use of the linear-quadratic radiobiological model for quantifying kidney response in targeted radiotherapy.
Dale R.
Cancer Biother Radiopharm. 2004 Jun;19(3):363-70. doi: 10.1089/1084978041425070.
PMID:15285884
Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.
Shibamoto Y, Otsuka S, Iwata H, Sugie C, Ogino H, Tomita N.
J Radiat Res. 2012;53(1):1-9. doi: 10.1269/jrr.11095. Epub 2011 Oct 14.